Developing a cost-effective device to monitor ultrafine airborne particles

A PULSED CONDENSATION PARTICLE COUNTER FOR COST EFFECTIVE MONITORING OF ULTRAFINE AIRBORNE PARTICLES

NIH-funded research Aerosol Dynamics, INC. · NIH-10599312

This study is working on a new, affordable device that can accurately measure tiny particles in the air that might affect your health, making it useful for places like schools and hospitals to help keep the air clean and safe.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionAerosol Dynamics, INC. NIH-funded
Lab location1 site (Berkeley, United States)
Project IDNIH-10599312 on NIH RePORTER

What this research studies

This research focuses on creating an affordable device called a Pulsed Condensation Particle Counter, which will accurately measure ultrafine airborne particles that are often linked to health issues. The device uses advanced techniques like adiabatic expansion and single particle counting to ensure reliable results over extended periods. By improving the performance and compactness of this monitoring system, the research aims to provide a tool that can be used in various environments, including schools and healthcare facilities, to assess air quality. The project includes rigorous testing in both laboratory and real-world settings to validate its effectiveness.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living in urban areas or environments with high levels of industrial activity, where ultrafine particles may pose health risks.

Not a fit: Patients who are not exposed to ultrafine airborne particles or live in rural areas with minimal air pollution may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better air quality monitoring, helping to reduce health risks associated with ultrafine particles.

How similar studies have performed: Previous research has shown success in developing advanced air quality monitoring technologies, indicating a promising potential for this novel approach.

Where this research is happening

Berkeley, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.